US Stock MarketDetailed Quotes

CPIX Cumberland Pharmaceuticals

Watchlist
  • 4.410
  • +0.280+6.78%
Close Mar 28 16:00 ET
  • 4.250
  • -0.160-3.63%
Post 20:01 ET
61.60MMarket Cap-9.59P/E (TTM)

Cumberland Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-4.26%37.87M
11.57%10.44M
-9.92%9.09M
-9.55%9.85M
-7.88%8.5M
-5.85%39.55M
2.51%9.35M
-11.63%10.09M
5.73%10.89M
-17.45%9.22M
Operating revenue
-2.60%36.54M
12.22%10.22M
-13.54%8.46M
-9.55%9.85M
-7.88%8.5M
-7.79%37.51M
16.84%9.11M
-14.25%9.79M
5.73%10.89M
-17.45%9.22M
Cost of revenue
8.56%6.59M
29.18%1.98M
-25.07%1.32M
12.50%1.71M
26.02%1.58M
-33.47%6.07M
-42.27%1.53M
-20.63%1.77M
-25.15%1.52M
-43.48%1.25M
Gross profit
-6.58%31.28M
8.13%8.46M
-6.70%7.76M
-13.13%8.14M
-13.19%6.92M
1.80%33.49M
20.85%7.82M
-9.45%8.32M
13.32%9.37M
-11.03%7.97M
Operating expense
-12.37%37.71M
-26.43%10.3M
-7.16%9.46M
-1.93%9.16M
-7.52%8.79M
11.51%43.04M
60.01%14M
7.49%10.19M
-7.60%9.35M
-7.30%9.51M
Selling and administrative expenses
-3.28%28.15M
-7.92%7.55M
-0.20%7.07M
-0.52%7.01M
-3.75%6.52M
8.43%29.1M
19.04%8.2M
12.91%7.09M
4.16%7.04M
-2.03%6.78M
-Selling and marketing expense
-7.74%17.02M
-11.28%4.22M
-7.29%4.4M
-9.07%4.25M
-2.87%4.15M
10.75%18.45M
40.83%4.76M
15.39%4.74M
2.53%4.67M
-7.31%4.28M
-General and administrative expense
4.46%11.13M
-3.28%3.33M
14.14%2.68M
16.34%2.76M
-5.25%2.37M
4.63%10.65M
-1.95%3.44M
8.21%2.34M
7.53%2.37M
8.54%2.5M
Research and development costs
-17.45%4.82M
2.21%1.29M
-32.14%1.31M
-7.50%1.06M
-22.77%1.16M
-12.78%5.83M
-10.04%1.26M
12.28%1.92M
-37.21%1.15M
-14.07%1.5M
Depreciation amortization depletion
-41.40%4.75M
-67.85%1.46M
-8.24%1.08M
-5.04%1.1M
-9.71%1.11M
59.90%8.1M
890.60%4.54M
-20.94%1.18M
-24.27%1.16M
-22.79%1.23M
-Depreciation and amortization
-41.40%4.75M
-67.85%1.46M
-8.24%1.08M
-5.04%1.1M
-9.71%1.11M
59.90%8.1M
890.60%4.54M
-20.94%1.18M
-24.27%1.16M
-22.79%1.23M
Operating profit
32.68%-6.43M
70.19%-1.84M
9.22%-1.69M
-4,591.40%-1.03M
-22.04%-1.87M
-67.48%-9.55M
-171.28%-6.18M
-546.81%-1.87M
101.24%22.86K
-18.55%-1.53M
Net non-operating interest income expense
28.86%-271.06K
-19.23%-116.59K
-494.04%-68.18K
52.42%-64.51K
84.00%-21.78K
21.86%-381.01K
26.89%-97.79K
91.01%-11.48K
-10.62%-135.57K
-31.52%-136.16K
Non-operating interest income
16.59%334.44K
31.69%106.67K
-29.83%69.19K
8.38%61.84K
92.76%96.75K
191.50%286.85K
77.26%81K
356.45%98.6K
278.74%57.06K
212.89%50.19K
Non-operating interest expense
-9.34%605.51K
24.87%223.26K
24.79%137.37K
-34.41%126.35K
-36.40%118.53K
13.97%667.86K
-0.37%178.79K
-26.29%110.08K
39.97%192.64K
55.85%186.35K
Other net income (expense)
-93.51%237.09K
0
-71.15%237.09K
497.17%3.65M
0
821.8K
60.60%981.81K
1.85M
Special income (charges)
-71.15%237.09K
--0
-71.15%237.09K
----
----
34.43%821.8K
--0
--821.8K
----
----
-Less:Other special charges
71.15%-237.09K
--0
71.15%-237.09K
----
----
-34.43%-821.8K
--0
---821.8K
----
----
Other non- operating income (expenses)
----
----
----
----
----
--2.83M
--0
----
--981.81K
--1.85M
Income before tax
-2.89%-6.47M
68.80%-1.96M
-44.42%-1.53M
-225.56%-1.09M
-1,155.12%-1.89M
-12.61%-6.28M
-160.29%-6.28M
-153.71%-1.06M
164.01%869.09K
112.84%179.22K
Income tax
-149.53%-22.67K
-328.39%-57K
64.92%11.44K
64.96%11.44K
64.92%11.44K
-33.52%45.77K
-48.17%24.96K
0.55%6.94K
0.54%6.94K
0.55%6.94K
Net income
-1.78%-6.44M
69.82%-1.9M
-44.56%-1.54M
-227.89%-1.1M
-1,204.25%-1.9M
-12.05%-6.33M
-156.21%-6.3M
-151.22%-1.06M
163.18%862.15K
112.28%172.29K
Net income continuous Operations
-1.78%-6.44M
69.82%-1.9M
-44.56%-1.54M
-227.89%-1.1M
-1,204.25%-1.9M
-12.05%-6.33M
-156.21%-6.3M
-151.22%-1.06M
163.18%862.15K
112.28%172.29K
Minority interest income
170.08%36.06K
128.72%2.18K
151.09%7.11K
-69.47%-17.03K
320.08%43.79K
35.53%-51.45K
60.07%-7.58K
4.57%-13.92K
65.41%-10.05K
-15.82%-19.9K
Net income attributable to the parent company
-3.19%-6.48M
69.75%-1.9M
-47.15%-1.54M
-224.47%-1.09M
-1,112.71%-1.95M
-12.73%-6.28M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.2K
113.87%192.18K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-3.19%-6.48M
69.75%-1.9M
-47.15%-1.54M
-224.47%-1.09M
-1,112.71%-1.95M
-12.73%-6.28M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.2K
113.87%192.18K
Basic earnings per share
-4.55%-0.46
68.18%-0.14
-57.14%-0.11
-233.33%-0.08
-1,500.00%-0.14
-15.79%-0.44
-158.82%-0.44
-133.33%-0.07
166.67%0.06
111.11%0.01
Diluted earnings per share
-4.55%-0.46
68.18%-0.14
-57.14%-0.11
-233.33%-0.08
-1,500.00%-0.14
-15.79%-0.44
-158.82%-0.44
-133.33%-0.07
166.67%0.06
111.11%0.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -4.26%37.87M11.57%10.44M-9.92%9.09M-9.55%9.85M-7.88%8.5M-5.85%39.55M2.51%9.35M-11.63%10.09M5.73%10.89M-17.45%9.22M
Operating revenue -2.60%36.54M12.22%10.22M-13.54%8.46M-9.55%9.85M-7.88%8.5M-7.79%37.51M16.84%9.11M-14.25%9.79M5.73%10.89M-17.45%9.22M
Cost of revenue 8.56%6.59M29.18%1.98M-25.07%1.32M12.50%1.71M26.02%1.58M-33.47%6.07M-42.27%1.53M-20.63%1.77M-25.15%1.52M-43.48%1.25M
Gross profit -6.58%31.28M8.13%8.46M-6.70%7.76M-13.13%8.14M-13.19%6.92M1.80%33.49M20.85%7.82M-9.45%8.32M13.32%9.37M-11.03%7.97M
Operating expense -12.37%37.71M-26.43%10.3M-7.16%9.46M-1.93%9.16M-7.52%8.79M11.51%43.04M60.01%14M7.49%10.19M-7.60%9.35M-7.30%9.51M
Selling and administrative expenses -3.28%28.15M-7.92%7.55M-0.20%7.07M-0.52%7.01M-3.75%6.52M8.43%29.1M19.04%8.2M12.91%7.09M4.16%7.04M-2.03%6.78M
-Selling and marketing expense -7.74%17.02M-11.28%4.22M-7.29%4.4M-9.07%4.25M-2.87%4.15M10.75%18.45M40.83%4.76M15.39%4.74M2.53%4.67M-7.31%4.28M
-General and administrative expense 4.46%11.13M-3.28%3.33M14.14%2.68M16.34%2.76M-5.25%2.37M4.63%10.65M-1.95%3.44M8.21%2.34M7.53%2.37M8.54%2.5M
Research and development costs -17.45%4.82M2.21%1.29M-32.14%1.31M-7.50%1.06M-22.77%1.16M-12.78%5.83M-10.04%1.26M12.28%1.92M-37.21%1.15M-14.07%1.5M
Depreciation amortization depletion -41.40%4.75M-67.85%1.46M-8.24%1.08M-5.04%1.1M-9.71%1.11M59.90%8.1M890.60%4.54M-20.94%1.18M-24.27%1.16M-22.79%1.23M
-Depreciation and amortization -41.40%4.75M-67.85%1.46M-8.24%1.08M-5.04%1.1M-9.71%1.11M59.90%8.1M890.60%4.54M-20.94%1.18M-24.27%1.16M-22.79%1.23M
Operating profit 32.68%-6.43M70.19%-1.84M9.22%-1.69M-4,591.40%-1.03M-22.04%-1.87M-67.48%-9.55M-171.28%-6.18M-546.81%-1.87M101.24%22.86K-18.55%-1.53M
Net non-operating interest income expense 28.86%-271.06K-19.23%-116.59K-494.04%-68.18K52.42%-64.51K84.00%-21.78K21.86%-381.01K26.89%-97.79K91.01%-11.48K-10.62%-135.57K-31.52%-136.16K
Non-operating interest income 16.59%334.44K31.69%106.67K-29.83%69.19K8.38%61.84K92.76%96.75K191.50%286.85K77.26%81K356.45%98.6K278.74%57.06K212.89%50.19K
Non-operating interest expense -9.34%605.51K24.87%223.26K24.79%137.37K-34.41%126.35K-36.40%118.53K13.97%667.86K-0.37%178.79K-26.29%110.08K39.97%192.64K55.85%186.35K
Other net income (expense) -93.51%237.09K0-71.15%237.09K497.17%3.65M0821.8K60.60%981.81K1.85M
Special income (charges) -71.15%237.09K--0-71.15%237.09K--------34.43%821.8K--0--821.8K--------
-Less:Other special charges 71.15%-237.09K--071.15%-237.09K---------34.43%-821.8K--0---821.8K--------
Other non- operating income (expenses) ----------------------2.83M--0------981.81K--1.85M
Income before tax -2.89%-6.47M68.80%-1.96M-44.42%-1.53M-225.56%-1.09M-1,155.12%-1.89M-12.61%-6.28M-160.29%-6.28M-153.71%-1.06M164.01%869.09K112.84%179.22K
Income tax -149.53%-22.67K-328.39%-57K64.92%11.44K64.96%11.44K64.92%11.44K-33.52%45.77K-48.17%24.96K0.55%6.94K0.54%6.94K0.55%6.94K
Net income -1.78%-6.44M69.82%-1.9M-44.56%-1.54M-227.89%-1.1M-1,204.25%-1.9M-12.05%-6.33M-156.21%-6.3M-151.22%-1.06M163.18%862.15K112.28%172.29K
Net income continuous Operations -1.78%-6.44M69.82%-1.9M-44.56%-1.54M-227.89%-1.1M-1,204.25%-1.9M-12.05%-6.33M-156.21%-6.3M-151.22%-1.06M163.18%862.15K112.28%172.29K
Minority interest income 170.08%36.06K128.72%2.18K151.09%7.11K-69.47%-17.03K320.08%43.79K35.53%-51.45K60.07%-7.58K4.57%-13.92K65.41%-10.05K-15.82%-19.9K
Net income attributable to the parent company -3.19%-6.48M69.75%-1.9M-47.15%-1.54M-224.47%-1.09M-1,112.71%-1.95M-12.73%-6.28M-157.89%-6.29M-156.78%-1.05M165.30%872.2K113.87%192.18K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -3.19%-6.48M69.75%-1.9M-47.15%-1.54M-224.47%-1.09M-1,112.71%-1.95M-12.73%-6.28M-157.89%-6.29M-156.78%-1.05M165.30%872.2K113.87%192.18K
Basic earnings per share -4.55%-0.4668.18%-0.14-57.14%-0.11-233.33%-0.08-1,500.00%-0.14-15.79%-0.44-158.82%-0.44-133.33%-0.07166.67%0.06111.11%0.01
Diluted earnings per share -4.55%-0.4668.18%-0.14-57.14%-0.11-233.33%-0.08-1,500.00%-0.14-15.79%-0.44-158.82%-0.44-133.33%-0.07166.67%0.06111.11%0.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.